Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment
Cheng Hu , Wenqi Liu , Jian Wang , Chen Hua , Linyu Long , Xia Yang , Lu Lu , Yun Zhu , Li Yang , Yunbing Wang , Xingdong Zhang
Collagen and Leather ›› 2025, Vol. 7 ›› Issue (1) : 38
Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment
Heart failure or myocardial infarction (MI) is among the leading causes of death worldwide. However, current therapeutic procedures, including pharmacological interventions and ventricular assist devices, are unable to reverse the pathological changes and regenerate the injured cardiac tissue. Here, tailored recombinant humanized collagen type I (rhCol I) with high bioactivity for myocardial tissue-related cells was loaded into injectable hydrogels to construct a microenvironment favorable for angiogenesis, myocardial tissue repair and the restoration of heart function after MI. rhCol I-loaded hydrogels (gel@rhCol I) had a good response to the MI microenvironment, which indicated that they can release rhCol I for MI treatment. In vitro and in vivo results showed that the gel@rhCol I is able to effectively promote myocardial tissue repair and restore cardiac function after MI by inhibiting cell apoptosis, downregulating pro-inflammatory factors and promoting angiogenesis. In conclusion, injectable hydrogel based on tailored rhCol I exhibited great potential in the repair of damaged myocardial tissue. More importantly, the discovery of the mechanism of rhCol I promoting the repair of damaged myocardial tissue will broaden the clinical application of rhCol I for MI or heart failure treatment.
Myocardial infarction / Injectable hydrogel / Tailored recombinant humanized collagen type I / Myocardial tissue repair
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovas Res. 2022;cvac013. |
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
Pournemati B, Tabesh H, Jenabi A, Aghdam RM, Rezayan AH, Poorkhalil A, Tafti SHA, Mottaghy K. Injectable conductive nanocomposite hydrogels for cardiac tissue engineering: focusing on carbon and metal-based nanostructures. Eur Polymer J. 2022; 174:111336. |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
Yin Q, Zhu P, Liu W, Gao Z, Zhao L, Wang C, Li S, Zhu M, Zhang Q, Zhang X, Wang C. A conductive bioengineered cardiac patch for myocardial infarction treatment by improving tissue electrical integrity. Adv Healthc Mater. 2022;n/a(n/a):2201856. |
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
Cuadrado I, Piedras MJGM, Herruzo I, Turpin MdC, Castejón B, Reventun P, Martin A, Saura M, Zamorano JL, Zaragoza C. EMMPRIN-targeted magnetic nanoparticles for in vivo visualization and regression of acute myocardial infarction. Theranostics. 2016;6(4):545-557. |
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
The Author(s)
/
| 〈 |
|
〉 |